COMP <GO>
LIVN vs JNJ // 10Y YIELD & FRED MACRO BETA
LivaNova PLC (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: LIVN 3
— JNJ 8
■ METRIC PARITY
LAST: $81.25 (+0.73%) • MKT CAP: $4.48B
macro-sensitivity
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LIVN VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LIVN | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.70% | 67.90% | -0.20 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.30% | 25.50% | -8.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.6x | 18.5x | -2.90 | LIVN | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | 2.97% | +0.90 | LIVN | /fcf-yield <GO> |
| Operating Margin | 14.40% | 34.70% | -20.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -17.50% | 28.50% | -46.00 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 10.70% | 6.00% | +4.70 | LIVN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.21 | 5.59 | -3.38 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.2 | 62.1 | -3.90 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.48B | $662.49B | -$658.02B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LIVN REV | JNJ REV | LIVN GROSS % | JNJ GROSS % | LIVN FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.39B | $94.19B | 67.7% | 67.9% | $173.3M | $19.70B |
| FY 2024 | $1.25B | $88.82B | 68.1% | 69.1% | $135.9M | $19.84B |
| FY 2023 | $1.15B | $85.16B | — | — | $74.9M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LIVN // BETA —
JNJ // BETA 1.08